Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1216 | 916 | 1290 | 2021 | 4326 | 5990 |
Fund Return | 21.57% | -8.36% | 29.02% | 26.43% | 34.04% | 19.6% |
Place in category | 156 | 185 | 159 | 27 | 2 | 14 |
% in Category | 82 | 97 | 86 | 14 | 1 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 271.61B | 28.51 | 30.36 | 21.80 | ||
INF966L01051 | 271.61B | 27.42 | 28.77 | 20.97 | ||
Quant Mid Cap Fund Growth | 89.41B | 20.35 | 24.39 | 18.45 | ||
Quant Consumption Fund Growth | 73.31B | 18.32 | 20.16 | 18.65 | ||
INF966L01721 | 35.85B | 26.45 | 26.36 | 19.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC MidCap Opportunities Dir Gr | 760.61B | 27.26 | 28.92 | 19.22 | ||
HDFC MidCap Opportunities Div | 760.61B | 26.48 | 28.00 | 17.98 | ||
HDFC MidCap Opportunities Growth | 760.61B | 26.49 | 28.04 | 18.25 | ||
HDFC MidCap Opportunities Dir Div | 760.61B | 27.25 | 28.88 | 18.99 | ||
Kotak Emerging Equity Scheme Divide | 520.49B | 32.15 | 23.17 | 18.69 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Reliance Industries | INE002A01018 | 9.43 | 1,218.00 | -2.65% | |
Aurobindo Pharma | INE406A01037 | 8.43 | 1,312.80 | -0.50% | |
Container Corp India | INE111A01025 | 7.58 | 763.60 | -2.83% | |
IRB Infrastructure | INE821I01022 | 7.37 | 57.27 | -5.04% | |
Tata Communications | INE151A01013 | 5.97 | 1,691.20 | -2.61% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review